Overview 
Day 1 
Day 2 
Register 
PDF Download 
Welcome Letter
Hotel & Travel 
Sponsor 
Press Pass 
Request Brochure
Complimentary Webcast 

 

Beardsworth logo

Commonwealth

IndiPharm

http://www.chidb.com/2008/pcg/images/neeman_medical.jpg 

http://www.chidb.com/2008/pcg//images/sigma.jpg

http://chidb.com/2008/pcg/images/ACRO

SABPA

Asia Pacific

US India Business Council

China Bio Accelerator

http://www.chidb.com/logos/SCIENCE_AAAS.jpg

http://www.chidb.com/logos/The_Scientist.jpg

Asia Monitor

Bentham

Bio-Outsourcing Asia

Business Monitor

BioSpectrum

ChinaBio Today

Emerging Europe Monitor

Espicom

The Pink Sheet

The Pink Sheet Daily

Pharma Agreement News

Pharma Company Insight

Pharm Asia News

Pharma Comp Analysis

Pharma Healthcare Insight

PharmaVoice

Reviews on Recent Clinical Trials

Thomson Centerwatch

WPM

Biolexis

Can Biotech

Pharmalicensing

PharmCast

Pharma China


 


Global R&D Congress: Discovery and Development Operations in Emerging Regions


Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

 

Register Yourself and a Peer (within or outside of your organization) at the Same Time
to Receive our VIP Rate!
Call David Cunningham at +1 781-972-5472 or Email cunningham@healthtech.com

This program is equal to 1.5 CEU's

Click here to view a list of Global R&D Congress Alumni

FEATURED PRESENTATIONS

A Critical Evaluation of Preclinical Testing in China: A Case Study
Dr. Diana Galer, Vice President, Strategic Management Group, Pfizer, Inc. 
Developing a Global Strategy to Further Innovation
Ross Horsburgh, Regional Medical Director, Asia Pacific & Head CRR-APAC, AstraZeneca 
Assessing Which Regions are Most Attractive and Why: A Perspective
Balu Balasubramanian, Ph.D., Executive Director, Research and Development, Bristol-Myers Squibb Co. 
Data Acceptability and Requirements in China: A Risk/Benefit Analysis
Dr. Lee Jia, Project Officer, Toxicology and Pharmacology Branch, DTP, National Cancer Institute/NIH 
Quality vs. Speed: A Regulatory Perspective on the Future Direction of Chinese SFDA and Role of China in Global Drug Development
Zili Li, M.D., M.P.H., Director of Clinical Research Operations-Asia Pacific/Head of China Regulatory Policy, Merck 
Translational Medicine and Biomarker Development Collaborations in China
Jingsong Wang, Ph.D., Director, Clinical Discovery, Bristol-Myers Squibb
Outsourcing Lead Generation Activities in China, India, and Russia
Deborah S. Hartman, Ph.D., Vice President, Lead Generation, AstraZeneca
How to Best Manage R&D Operations in China to Maximize Productivity
Samantha Ying Du, Ph.D., CEO, Hutchison MediPharma Ltd. 
ElenaBarmanova R&D in Russia Today: Regulatory Overview and Best Practices when Working with Local Authorities
Elena Barmanova, Deputy Director, Office for Registration of Drugs and Medical Devices, Federal department for Surveillance in Healthcare, Roszdravnadzor, Russia

Gilles Cottier

Operational Challenges when Sourcing the Globe for Discovery Efforts
Gilles Cottier, President, Sigma-Aldrich

Planning a Global Strategy Around Intellectual Property Law: IP Barriers, and Trends

Partnering for Medicinal Chemistry, Pharmacology, Animal Models, and GLP Tox
Beyond chemistry and biology outsourcing, what can be done outside of the US and Europe and what are the true possibilities, costs, constraints and efficiencies?

Intellectual Property • Partnering and Collaborations • Regulatory Landscape and Drug Registration • Deals, Licensing, and Risk-sharing • Accessing, Keeping and Managing Talent • International Project and Team Management • Discovery Chemistry • Discovery Biology • Pre-clinical Safety • Investigational Product Supply • Translational Medicine

Distinguished Faculty

Balu Balasubramanian, Ph.D., Executive Director, Research and Development, Bristol-Myers Squibb Co. Col. Aizen J. Marrogi, M.D., Department of Pathology and Area Laboratory Service, Walter Reed Army Medical Center
Dr. Diana Galer, Vice President, Strategic Management Group, Pfizer, Inc. Dr. David Moskowitz, CEO, GenoMed, Inc.
Deborah S. Hartman, Ph.D., Vice President, Lead Generation, AstraZeneca Dr. Vyas Shingatgeri, Director, Drug Safety Evaluation, Ranbaxy Research Laboratories
Mak Jawadekar, Ph.D., Director, WWPM, Pfizer Global R&D Vijay Soni, Executive Vice President – IP, Glenmark Pharma
Gregory E. Kalbaugh, Director and Counsel, U.S.-India Business Council Mr. Omar Vikin, Director, Global Strategic Accounts, Sigma-Aldrich Corporation
Lee Jia, Ph.D., Project Manager, Toxicology and Pharmacology Branch, DTP, National Cancer Institute/NIH Jingsong Wang, Ph.D., Director, Clinical Discovery, Bristol-Myers Squibb
Zili Li, M.D., M.P.H., Director of Clinical Research Operations-Asia Pacific/Head of China Regulatory Policy, Merck Samantha Ying Du, Ph.D., CEO, Hutchison MediPharma Ltd.
Dr. Ying Luo, CEO, GNI, Ltd. and Shanghai Genomics, Inc. Elena Barmanova, Deputy Director, Office for Registration of Drugs and Medical Devices, Federal department for Surveillance in Healthcare, Roszdravnadzor, Russian Federation
Dhanapalan Nagarathnam, Ph.D., Director, Medicinal Chemistry, Pharmasset, Inc. Ross Horsburgh, Regional Medical Director, Asia Pacific & Head CRR-APAC, AstraZeneca 
Gopala Krishna, PhD, DABT, MBA, Senior Director and Head, Preclinical Candidate Evaluation, Supernus Pharmaceuticals, Inc. Kelly P. Longo, Director, Strategic Alliances, Pfizer Inc.
Cris Howard, MBA, MEd, Senior Manager, Clinical Operations, Emergent BioSolutions Sudhir Borgonha, M.D., Chief Executive Officer, Translational Medicine India
Donald Swankie, Director, Neeman Medical International Gilles Cottier, President, Sigma-Aldrich
Art Gertel, Vice President, Clinical Services, Regulatory, & Medical Writing Beardsworth Consulting Group, Inc.

Robert Ward, Vice President, Alliance Management, NPS Pharmaceuticals

M. (Ken) Kengatharan, Ph.D., MBA, Vice President, Scientific Affairs, CoMentis Inc.

Pavle Vukojevic, M.D., Global Medical Director, Pharm-Olam International Ltd.

Frank J. Malinoski, MD, Ph.D., Senior Vice President, Medical and Scientific Affairs, MedImmune, Inc.

Dr. Paul D’Sylva, CEO, Commonwealth Biotechnologies, Inc. (CBI)

Edward J. Brennan, Jr., MD, FACS, President and CEO, IndiPharm LLC

Chris Israel, International Intellectual Property Enforcement, US Dept Of Commerce
D. Christopher Ohly, Partner, Schiff Hardin LLP Ningling Wang, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP


complimentary 

Featuring Two Presentations Focusing on Issues at the
Forefront of Drug Development in Asia

Wednesday, April 30 from 12:30 PM -1:30 PM ET (US)

View Full Details

 

Register

 

Presentation 1-CHINA:
Conducting High Quality, Cost Effective GLP Safety Studies in China -- Moving from If and When to HOW
Presentation 2-INDIA:
CASE STUDY: How Moving a POC Study to India Took 12+ Months off the Timeline for a Western Biotech


By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs